Showing results (2751-2760 of 6,517) with videos related to
Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|January 1, 1987
IgM response and resistance to ascites tumor growthJ L Subiza, J Coll, R Alvarez, et al.Cancer Immunology, Immunotherapy : CII|January 16, 2023
Endosialin-positive tumor-derived pericytes promote tumor progression through impeding the infiltration of CD8+ T cells in clear cell renal cell carcinomaTong Lu, Jiayu Zhang, Shiqi Lu, et al.Cancer Immunology, Immunotherapy : CII|January 5, 2023
Effects of the STAMP-inhibitor asciminib on T cell activation and metabolic fitness compared to tyrosine kinase inhibition by imatinib, dasatinib, and nilotinibLukas Häselbarth, Axel Karow, Kristin Mentz, et al.Cancer Immunology, Immunotherapy : CII|June 28, 2021
Prognostic significance of cachexia in advanced non-small cell lung cancer patients treated with pembrolizumabHitomi Jo, Tatsuya Yoshida, Hidehito Horinouchi, et al.Cancer Immunology, Immunotherapy : CII|January 8, 2021
Run for your life: an integrated virtual tissue platform for incorporating exercise oncology into immunotherapyJosua Aponte Serrano, Amit HagarCancer Immunology, Immunotherapy : CII|January 8, 2021
Increased expression of adenosine 2A receptors in metastatic renal cell carcinoma is associated with poorer response to anti-vascular endothelial growth factor agents and anti-PD-1/Anti-CTLA4 antibodies and shorter survivalTakao Kamai, Toshiki Kijima, Toyonori Tsuzuki, et al.Cancer Immunology, Immunotherapy : CII|January 13, 2021
A template to quantify the location and density of CD3 + and CD8 + tumor-infiltrating lymphocytes in colon cancer by digital pathology on whole slides for an objective, standardized immune score assessmentDordi Lea, Martin Watson, Ivar Skaland, et al.Cancer Immunology, Immunotherapy : CII|January 13, 2021
CD27 enhances the killing effect of CAR T cells targeting trophoblast cell surface antigen 2 in the treatment of solid tumorsHuanpeng Chen, Fengjiao Wei, Meng Yin, et al.Cancer Immunology, Immunotherapy : CII|June 6, 2021
Increased serum cholesterol and long-chain fatty acid levels are associated with the efficacy of nivolumab in patients with non-small cell lung cancerMasato Karayama, Naoki Inui, Yusuke Inoue, et al.Cancer Immunology, Immunotherapy : CII|June 7, 2021
ICI plus chemotherapy prolonged survival over ICI alone in patients with previously treated advanced NSCLCShiqi Mao, Fei Zhou, Yiwei Liu, et al.Pageof 652